Related Experiment Video

Updated: Jun 28, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis

T Takabayashi1, E Vannier, B D Clark

  • 1The Tupper Research Institute, Department of Medicine, Tufts University School of Medicine, Boston, MA 02111, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|May 1, 1996
PubMed

Insights

Complement activation products C3a and C3a desArg modulate inflammation by affecting tumor necrosis factor-alpha and interleukin-1 beta. These molecules can suppress systemic cytokine production while enhancing local inflammatory responses.

Area of Science:

  • Immunology
  • Complement System Biology

Background:

  • Complement activation products C3a and C3a desArg are generated during trauma, infection, and tissue injury.
  • These molecules are implicated in inflammatory processes, but their precise roles in cytokine regulation are not fully understood.

Purpose of the Study:

  • To investigate the effects of C3a and C3a desArg on the gene expression and protein synthesis of TNF-alpha and IL-1 beta in peripheral blood mononuclear cells (PBMC).

Main Methods:

  • PBMC were stimulated with lipopolysaccharide (LPS) in the presence or absence of C3a and C3a desArg.
  • Gene expression (mRNA levels) and protein synthesis of TNF-alpha and IL-1 beta were measured.
  • Experiments were conducted using both nonadherent and adherent PBMC populations.

Main Results:

  • Neither C3a nor C3a desArg alone induced TNF-alpha or IL-1 beta.
  • In nonadherent PBMC, C3a suppressed LPS-induced TNF-alpha and IL-1 beta synthesis and mRNA levels.
  • In adherent PBMC, C3a enhanced LPS-induced TNF-alpha and IL-1 beta synthesis and mRNA levels.
  • C3a desArg demonstrated similar modulatory effects on cytokine production as C3a.

Conclusions:

  • C3a and C3a desArg act as modulators of inflammation, challenging the view of C3a desArg as biologically inactive.
  • These complement products exhibit differential effects on cytokine synthesis depending on the cellular context, potentially enhancing local inflammation while suppressing systemic responses.

More Related Videos

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints10:10

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

Published on: December 9, 2025

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...